Labopharm Inc (DDS-T) Stock Predictions - Stockchase
WATCH LIST
28
Labopharm Inc (DDS-T)

ON STOCKCHASE SINCE Jul 2001

Acquired by Paladin Labs

biotechnology/pharmaceutical

Labopharm Inc

DDS-T

2 watching          
Join the Discussion

Labopharm Inc (DDS-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about DDS-T



  • All
  • Filtered
Signal Opinion Expert
HOLD
Labopharm Inc(DDS-T) 

January 8, 2009

Broke through the 200-day moving average at about $1.50. Looks like the momentum may start to peter out but there is some pretty good support around $1.40. If her broke that, you should Sell.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Broke through the 200-day moving average at about $1.50. Looks like the momentum may start to peter out but there is some pretty good support around $1.40. If her broke that, you should Sell.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Hap (Robert) Sn

Chief Port, Castlemoore Inc....

Price Price
$1.830
Owned Owned
Unknown

DON'T BUY
Labopharm Inc(DDS-T) 

December 14, 2007

Has disappointed everyone for a long time. Didn't get approval on their product. Stock has been decimated. Thinks the worst is over, but it will be a long recovery. He was actually Short the stock for a while. If you own, Hold and see what they do, but don't be a buyer.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has disappointed everyone for a long time. Didn't get approval on their product. Stock has been decimated. Thinks the worst is over, but it will be a long recovery. He was actually Short the stock for a while. If you own, Hold and see what they do, but don't be a buyer.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$1.070
Owned Owned
No

SELL
Labopharm Inc(DDS-T) 

November 15, 2007

Has been a major disappointment. Guided that approvals would be fairly easy to receive, which didn't happen. Trials have been okay, not all that inclusive, so there is a lot of uncertainty.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has been a major disappointment. Guided that approvals would be fairly easy to receive, which didn't happen. Trials have been okay, not all that inclusive, so there is a lot of uncertainty.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Lesley Marks

Vice Presi, Jones Heward Investm...

Price Price
$1.230
Owned Owned
No

BUY
Labopharm Inc(DDS-T) 

November 6, 2006

Has been doing fairly well recently because they had their European and Canadian approval for their painkiller. Once they get the US of the way, it should be back over the $7 mark.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has been doing fairly well recently because they had their European and Canadian approval for their painkiller. Once they get the US of the way, it should be back over the $7 mark.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Chyanne Fickes

Vice Presi, Stone Funds...

Price Price
$5.560
Owned Owned
Unknown

BUY
Labopharm Inc(DDS-T) 

October 2, 2006

It is a small stock. Believes it will be a winner.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
It is a small stock. Believes it will be a winner.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Chyanne Fickes

Vice Presi, Stone Funds...

Price Price
$5.830
Owned Owned
No

WATCH
Labopharm Inc(DDS-T) 

August 23, 2005

Entering into a licensing/distribution agreement with Purdue Pharma in the US. Did a disatrous financing last year and the stock sold off. This deal was a rabbit pulled out of a hat. The stock will probably flatline for a bit after this deal. Best to see quarter after quarter how revenues kick in.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Entering into a licensing/distribution agreement with Purdue Pharma in the US. Did a disatrous financing last year and the stock sold off. This deal was a rabbit pulled out of a hat. The stock will probably flatline for a bit after this deal. Best to see quarter after quarter how revenues kick in.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$4.890
Owned Owned
No

DON'T BUY
Labopharm Inc(DDS-T) 

January 17, 2005

Received approval in France for its drug tramadol. Has stubbed its toes many times with investors. Large outstanding stock holding (40 Million?) could come out and flood the market.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Received approval in France for its drug tramadol. Has stubbed its toes many times with investors. Large outstanding stock holding (40 Million?) could come out and flood the market.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew McCreath

Senior Por, Sentry Select Capita...

Price Price
$4.170
Owned Owned
No

DON'T BUY
Labopharm Inc(DDS-T) 

January 17, 2005

Drug companies in general scare value investors. Drugs they produce might injure or kill people. Also there's a history of companies suing each other because of infringement on property rights which can tie up a small company like this. Although they got French approval, FDA could be a whole different matter.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Drug companies in general scare value investors. Drugs they produce might injure or kill people. Also there's a history of companies suing each other because of infringement on property rights which can tie up a small company like this. Although they got French approval, FDA could be a whole different matter.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Baskin

President, Baskin Wealth Manage...

Price Price
$4.170
Owned Owned
No

WATCH
Labopharm Inc(DDS-T) 

August 26, 2004

Management is at its risk. If they start in Europe, the stock will improve. Therefore, be cautious.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Management is at its risk. If they start in Europe, the stock will improve. Therefore, be cautious.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Glenn Paradis,

Vice Presi, Aegon Capital Manage...

Price Price
$4.030
Owned Owned
Unknown

DON'T BUY
Labopharm Inc(DDS-T) 

May 17, 2004

Did an issue and it was a disaster. Hasn't even come close to where the issue was priced at. Behind schedule as compared to their competitors.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Did an issue and it was a disaster. Hasn't even come close to where the issue was priced at. Behind schedule as compared to their competitors.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$4.090
Owned Owned
No

DON'T BUY
Labopharm Inc(DDS-T) 

May 29, 2003

Still suffering from a plethora of disappointments from late 2001 and 2002. Will have a challenge moving up from where it is. Prefers others.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Still suffering from a plethora of disappointments from late 2001 and 2002. Will have a challenge moving up from where it is. Prefers others.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew McCreath

Senior Por, Sentry Select Capita...

Price Price
$5.180
Owned Owned
Unknown

DON'T BUY
Labopharm Inc(DDS-T) 

May 17, 2002

Volatile. Too few projects on the go. Risky.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Volatile. Too few projects on the go. Risky.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bruce Cooper

Portfolio , T.D. Asset...

Price Price
$5.340
Owned Owned
Unknown

DON'T BUY
Labopharm Inc(DDS-T) 

May 2, 2002

Interesting technology. Future is unclear. Risky.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Interesting technology. Future is unclear. Risky.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bruce Cooper

Portfolio , T.D. Asset...

Price Price
$4.750
Owned Owned
Unknown

PAST TOP PICK
Labopharm Inc(DDS-T) 

April 1, 2002

(Was a top pick on Dec 18 down 46%) Still likes. Got hit with the pull out of Aventis, but should be able to get new deals over the next 6 months. Don't buy until they do strike a deal.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Was a top pick on Dec 18 down 46%) Still likes. Got hit with the pull out of Aventis, but should be able to get new deals over the next 6 months. Don't buy until they do strike a deal.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Glenn Paradis,

Vice Presi, Aegon Capital Manage...

Price Price
$5.800
Owned Owned
Unknown

DON'T BUY
Labopharm Inc(DDS-T) 

March 15, 2002

Speculative and risky. In a competitive sector.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Speculative and risky. In a competitive sector.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jonathen Wellum

Chief Exec, AIC Limited...

Price Price
$5.380
Owned Owned
Unknown

Showing 1 to 15 of 28 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days